Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Current Treatment Options in Oncology|May 4, 2023
An Update on Appendiceal Neuroendocrine TumorsElisa Andrini, Giuseppe Lamberti, Laura Alberici, et al.Future Oncology (London, England)|June 17, 2020
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implicationGiuseppe Lamberti, Elisa Andrini, Monia Sisi, et al.Tumori|February 5, 2022
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparitiesAndrea De Giglio, Valentina Orlando, Elisa Andrini, et al.Journal of Neuroendocrinology|February 4, 2026
Determinants of incidence trends in pancreatic neuroendocrine neoplasmsGiuseppe Lamberti, Elisa Andrini, Adriana Di Odoardo, et al.Drugs in Context|August 1, 2022
Non-small-cell lung cancer: how to manage RET-positive diseaseElisa Andrini, Mirta Mosca, Linda Galvani, et al.Current Oncology (Toronto, Ont.)|February 25, 2025
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine NeoplasmsGraziella Masciangelo, Davide Campana, Claudio Ricci, et al.The Annals of Otology, Rhinology, and Laryngology|August 8, 2026
Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population StudyAndrea Carlini, Mirea Berti, Giuseppe Lamberti, et al.Journal of Clinical Medicine|August 28, 2025
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and PerspectivesAnna Scognamiglio, Arianna Zappi, Elisa Andrini, et al.Current Oncology (Toronto, Ont.)|February 24, 2023
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine TumorsNicole Brighi, Giuseppe Lamberti, Elisa Andrini, et al.Cancers|October 29, 2020
The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?Giuseppe Lamberti, Monia Sisi, Elisa Andrini, et al.Pageof 5